Advertisement
Advertisement
U.S. markets open in 2 hours 57 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Landec Corporation (LNDC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.98+0.18 (+1.67%)
At close: 04:00PM EST
10.98 0.00 (0.00%)
After hours: 04:01PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close10.80
Open10.73
Bid0.00 x 800
Ask0.00 x 800
Day's Range10.65 - 11.16
52 Week Range7.65 - 12.88
Volume95,356
Avg. Volume148,362
Market Cap323.705M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-1.92
Earnings DateApr 05, 2022 - Apr 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LNDC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Landec Corporation
    Daily – Vickers Top Buyers & Sellers for 01/18/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • GlobeNewswire

    Landec Corporation to Showcase Lifecore Biomedical at the 2022 ICR Conference on Monday, January 10, 2022

    SANTA MARIA, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – today announced that Jim Hall, P

  • Zacks

    Landec (LNDC) Reports Q2 Loss, Misses Revenue Estimates

    Landec (LNDC) delivered earnings and revenue surprises of -212.50% and 2.16%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Landec Corporation Reports Second Quarter Fiscal Year 2022 Results

    Reiterates Fiscal 2022 Guidance for Lifecore Provides Pro Forma Curation Foods Segment Results and Updates Guidance for Continuing Segment Operations SANTA MARIA, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. ("Lifecore") and Curation Foods, Inc., reported results for the fiscal 2022 second quarter ended November 28, 2021. Subsequent to fis

Advertisement
Advertisement